相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Innate immunity in diabetic kidney disease
Sydney C. W. Tang et al.
NATURE REVIEWS NEPHROLOGY (2020)
Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway
Shu Yang et al.
PHARMACOLOGICAL RESEARCH (2020)
Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy
Yujia Yuan et al.
STEM CELLS (2020)
Inflammatory Targets in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population
Zuray Corredor et al.
SCIENTIFIC REPORTS (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
The role of complement in kidney disease
Jamie Willows et al.
CLINICAL MEDICINE (2020)
The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy
Ting-Ting Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
Priscila Calle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Editorial: Role of NOD-Like Receptors in Infectious and Immunological Diseases
Christopher R. Lupfer et al.
FRONTIERS IN IMMUNOLOGY (2020)
Special Issue Diabetic Nephropathy: Diagnosis, Prevention and Treatment
Marta Ruiz-Ortega et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Attenuation of Diabetic Nephropathy in Diabetic Mice by Fasudil through Regulation of Macrophage Polarization
Fajiang Xie et al.
JOURNAL OF DIABETES RESEARCH (2020)
The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies
Maria Tziastoudi et al.
CLINICAL KIDNEY JOURNAL (2020)
Pattern recognition receptor-mediated inflammation in diabetic vascular complications
Xu Wang et al.
MEDICINAL RESEARCH REVIEWS (2020)
TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathy
Hanxu Zeng et al.
INFLAMMATION RESEARCH (2020)
The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
Li Wang et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
Swetha R. Kanduri et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Empagliflozin Attenuates Renal and Urinary Markers of Tubular Epithelial Cell Injury in Streptozotocin-induced Diabetic Rats
Zahra Ashrafi Jigheh et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2020)
Complement deposition on renal histopathology of patients with diabetic nephropathy
Z. J. Sun et al.
DIABETES & METABOLISM (2019)
Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy
Carolina Lavoz et al.
KIDNEY INTERNATIONAL (2019)
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo J. L. Heerspink et al.
DIABETOLOGIA (2019)
circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells
Bin Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons
Javier Donate-Correa et al.
JOURNAL OF CLINICAL MEDICINE (2019)
IL-18, VCAM-1 and P-selectin as early biomarkers in normoalbuminuric Type 2 diabetes patients
Khalid Al-Rubeaan et al.
BIOMARKERS IN MEDICINE (2019)
Roles of Inflammasomes in Inflammatory Kidney Diseases
Jinjin Fan et al.
MEDIATORS OF INFLAMMATION (2019)
Pathological significance of urinary complement activation in diabetic nephropathy: A full view from the development of the disease
Jing-Min Zheng et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice
Masa-Ki Inoue et al.
DIABETOLOGY & METABOLIC SYNDROME (2019)
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Heidi Harjunpaa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Genetic and Epigenetic Studies in Diabetic Kidney Disease
Harvest F. Gu
FRONTIERS IN GENETICS (2019)
Macrophage phenotype and its relationship with renal function in human diabetic nephropathy
Xiaoliang Zhang et al.
PLOS ONE (2019)
Complement Inhibitors in Clinical Trials for Glomerular Diseases
Peter F. Zipfel et al.
FRONTIERS IN IMMUNOLOGY (2019)
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
CongXiao Zhang et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy
Kehong Chen et al.
FASEB JOURNAL (2019)
Long noncoding RNA Gm6135 functions as a competitive endogenous RNA to regulate toll-like receptor 4 expression by sponging miR-203-3p in diabetic nephropathy
Ting-Ting Ji et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Evolving spectrum of diabetic nephropathy
Jonathan Kopel et al.
WORLD JOURNAL OF DIABETES (2019)
New insights into the immune functions of complement
Edimara S. Reis et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy
Wai Han Yiu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Steven J. Forrester et al.
CIRCULATION RESEARCH (2018)
The role of toll-like receptors in diabetic kidney disease
Usha Panchapakesan et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
Claire C. J. Dekkers et al.
DIABETES OBESITY & METABOLISM (2018)
Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice
Atsuo Tahara et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation
Peipei Luan et al.
FASEB JOURNAL (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Complement 7 Is Up-Regulated in Human Early Diabetic Kidney Disease
Monica Sircar et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes
Tomas Vaisar et al.
DIABETES CARE (2018)
Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells
Shan Song et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice
Ming Wu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Do We Know Jack About JAK? A Closer Look at JAK/STAT Signaling Pathway
Emira Bousoik et al.
FRONTIERS IN ONCOLOGY (2018)
Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy
Jeremy D. Gale et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria
Zahra Karimi et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2018)
Complement Activation in Patients With Diabetic Nephropathy
Pascal Bus et al.
KIDNEY INTERNATIONAL REPORTS (2018)
The Susceptibility Genes in Diabetic Nephropathy
Ling Wei et al.
KIDNEY DISEASES (2018)
Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy
Xin Wang et al.
DIABETES (2017)
An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
Daniel S. Hsia et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
Daiji Kawanami et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium
Fei Tong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
The role of the complement system in diabetic nephropathy
Allan Flyvbjerg
NATURE REVIEWS NEPHROLOGY (2017)
The NF-κB1 is a key regulator of acute but not chronic renal injury
Amy Fearn et al.
CELL DEATH & DISEASE (2017)
Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
Saket Gupta et al.
SCIENTIFIC REPORTS (2017)
Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy
Ying Fu et al.
MEDICAL SCIENCE MONITOR (2017)
Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes
Li Tang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat
Manash P. Borgohain et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
NOD2 promotes endothelial-to-mesenchymal transition of glomerular endothelial cells via MEK/ERK signaling pathway in diabetic; nephropathy
Jin Shang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Innate immunity in diabetes and diabetic nephropathy
Jun Wada et al.
NATURE REVIEWS NEPHROLOGY (2016)
JAK inhibition in the treatment of diabetic kidney disease
Frank C. Brosius et al.
DIABETOLOGIA (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Tubular Epithelial NF-κB Activity Regulates Ischemic AKI
Lajos Marko et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease
Hans-Joachim Anders
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Yuan-ye Qiu et al.
PHARMACOLOGICAL RESEARCH (2016)
NOD-Like Receptors in Infection, Immunity, and Diseases
Young Keun Kim et al.
YONSEI MEDICAL JOURNAL (2016)
High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
Hong Feng et al.
JOURNAL OF DIABETES RESEARCH (2016)
Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy
Fang Yuan et al.
PLOS ONE (2016)
JAK inhibition and progressive kidney disease
Frank C. Brosius et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy
Huei-Fen Jheng et al.
DISEASE MODELS & MECHANISMS (2015)
Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation
Huaibin Sun et al.
INFLAMMATION (2015)
Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy
Helena Cucak et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes
Jian-Jun Liu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2
Barbara Ruszkowska-Ciastek et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2015)
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury
Alaa S. Awad et al.
KIDNEY INTERNATIONAL (2015)
Relevance of TNF-α in the context of other inflammatory cytokines in the progression of diabetic nephropathy
Lin Sun et al.
KIDNEY INTERNATIONAL (2015)
C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease
Ling Li et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration
Qilu Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Inflammatory Cytokines in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF DIABETES RESEARCH (2015)
Role of Toll-like receptors in diabetic renal lesions in a miniature pig model
Yuanyuan Feng et al.
SCIENCE ADVANCES (2015)
Role of Transcription Factor Acetylation in Diabetic Kidney Disease
Ruijie Liu et al.
DIABETES (2014)
Global toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy
Ishwarlal Jialal et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production
Kang He et al.
KIDNEY INTERNATIONAL (2014)
Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
Naoto Terami et al.
PLOS ONE (2014)
TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy
Jin Ma et al.
PLOS ONE (2014)
C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-beta/smad3 and IKB alpha Pathway
Ling Li et al.
PLOS ONE (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension
Florian Gembardt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Diabetic nephropathy - complications and treatment
Andy K. H. Lim
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Inflammation in diabetic kidney disease
Patricia M. Garcia-Garcia et al.
WORLD JOURNAL OF DIABETES (2014)
Identification of Cross-Species Shared Transcriptional Networks of Diabetic Nephropathy in Human and Mouse Glomeruli
Jeffrey B. Hodgin et al.
DIABETES (2013)
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hye-Mi Lee et al.
DIABETES (2013)
Renal Protective Effects of Toll-like Receptor 4 Signaling Blockade in Type 2 Diabetic Mice
J. J. Cha et al.
ENDOCRINOLOGY (2013)
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Kehong Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy
Pengchao Du et al.
KIDNEY INTERNATIONAL (2013)
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
Miao Lin et al.
KIDNEY INTERNATIONAL (2013)
Macrophages directly mediate diabetic renal injury
Hanning You et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
Jun Panee
CYTOKINE (2012)
Profibrotic Effect of Interleukin-18 in HK-2 Cells Is Dependent on Stimulation of the Toll-like Receptor 4 (TLR4) Promoter and Increased TLR4 Expression
Kirstan K. Meldrum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Bikash Debnath et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
Miao Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Pro-/anti-inflammatory cytokine gene polymorphisms and chronic kidney disease: a cross-sectional study
Rieko Okada et al.
BMC NEPHROLOGY (2012)
Inactivation of TNF-α ameliorates diabetic neuropathy in mice
Isamu Yamakawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Crosstalk of reactive oxygen species and NF-kappa B signaling
Michael J. Morgan et al.
CELL RESEARCH (2011)
Transcriptome Analysis of Human Diabetic Kidney Disease
Karolina I. Woroniecka et al.
DIABETES (2011)
Suppressor of Cytokine Signaling-1 Ameliorates Expression of MCP-1 in Diabetic Nephropathy
Yonghong Shi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
NF-κB in Renal Inflammation
Ana Belen Sanz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
Guadalupe Ortiz-Munoz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21
Ana B. Sanz et al.
PLOS ONE (2010)
Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
Celine C. Berthier et al.
DIABETES (2009)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Ting-Chi Lu et al.
KIDNEY INTERNATIONAL (2009)
Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
Su-Ryun Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state
Sridevi Devaraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Yuji Moriwaki et al.
ACTA DIABETOLOGICA (2007)
Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients
Juan F. Navarro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
FY Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats
K Kalantarinia et al.
KIDNEY INTERNATIONAL (2003)
IKKε and TBK1 are essential components of the IRF3 signaling pathway
KA Fitzgerald et al.
NATURE IMMUNOLOGY (2003)
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy
T Morii et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes - Progressive, interrelated, and independently associated with risk of death
CDA Stehouwer et al.
DIABETES (2002)
分享论文
